RNA, U2 small nuclear 69, pseudogene (RNU2-69P)

RNU2-69P (RNA, U2 small nuclear 69, pseudogene) is annotated as a pseudogene related to the U2 small nuclear RNA gene family, which encodes U2 snRNAs involved in the splicing of pre-mRNA as part of the major spliceosome. Unlike canonical U2 snRNA genes such as RNU2-1 and the recently characterized RNU2-2, RNU2-69P is considered a nonfunctional segment with no known coding capacity, biological function, or disease association. Recent advances have clarified that several loci previously annotated as U2 pseudogenes (notably RNU2-2P, now RNU2-2) are functionally expressed and can be linked to human genetic disease, but there is currently no evidence that RNU2-69P is such a locus. There are no recognized drugs, biomarkers, or disease links specific to RNU2-69P, and it is not considered a therapeutic target, receptor, or druggable protein. The U2 snRNA gene family includes multiple genomic loci, some of which are multicopy, paralogous, and historically misannotated as pseudogenes due to high sequence similarity and lack of clear functional annotation in older genome builds. The specific designation "RNU2-69P" does not correspond to a recognized functional locus in current genetic or therapeutic literature, in contrast to new findings for RNU2-2 and RNU2-1. The gene described here should not be confused with canonical U2 snRNA gene loci that have recently been linked to severe human disease. Most gene/protein databases (such as GeneCards) list RNU2-69P as a pseudogene only, with no experimentally validated function, disease role, or druggability.

Other names

RNU2-69P

Not applicable